AstraZeneca GmbH

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 5
Amount won alone: €216,000 excl. VAT
Shared contracts: 2 (multi-supplier framework agreements)
Period: 26 January 2024 – 13 October 2026

Its main clients

Kliniczny Szpital Wojewódzki im. św. Jadwigi Królowej w Rzeszowie · 1 contract
AOK Baden-Württemberg · 1 contract
DAK-Gesundheit · 1 contract
PBMG eG · 1 contract
Hospilim VZW · 1 contract

Where and what

Supplies · 5

Limburg · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
30 June 2027 re-tender around December 2026	Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 PBMG eG framework agreement	ASTRAZENECA GMBH 1 bid received	–
20 August 2027 re-tender around February 2027	Zakup i dostawy leków do programów lekowych, cytostatyków oraz leków stosowanych w ramach procedury rdtl Kliniczny Szpital Wojewódzki im. św. Jadwigi Królowej w Rzeszowie	Urtica Sp. z o.o. LEK SPÓŁKA AKCYJNA Sanofi Spółka z o.o AstraZeneca ASCLEPIOS S.A. Komtur Polska Sp. z o.o. Janssen-Cilag Polska sp. z o.o. Abbvie Sp. z o.o. MEDIS farmacevtska druzba d.o.o. 5 bids received	–
12 December 2027 re-tender around June 2027	Raamovereenkomst voor het leveren van Cytostatica Parenteraal Hospilim VZW framework agreement	Roche NV Accord Healthcare BV Celltrion Healthcare Netherlands BV Pharmanovia Benelux BV Viatris BV Fresenius Kabi NV Baxter Belgium SRL Aurobindo NV AstraZeneca NV Arega Pharma BV Servier Benelux NV MSD Belgium BV Sandoz NV 4 bids received	€375,000,000
30 September 2028 re-tender around March 2028	Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff Tezepelumab AOK Baden-Württemberg framework agreement	AstraZeneca GmbH 1 bid received	€216,000

Contracts won

Date	Contract	Buyer	Amount
13/10/2026	Zakup i dostawy leków do programów lekowych, cytostatyków oraz leków stosowanych w ramach procedury rdtl	Kliniczny Szpital Wojewódzki im. św. Jadwigi Królowej w Rzeszowie	–
09/10/2026	Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff Tezepelumab	AOK Baden-Württemberg	€216,000
01/10/2026	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2024 - 30.09.2026	DAK-Gesundheit	€1 shared by 10
07/07/2026	Arzneimittelvergaben zum 01.01.2026 und 01.07.2026	PBMG eG	–
26/01/2024	Raamovereenkomst voor het leveren van Cytostatica Parenteraal	Hospilim VZW	€375,000,000 shared by 13

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.